SCHEMBL7324917

SCHEMBL7324917

CC(=O)c1c(N2CCOCC2)oc2ccccc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
PRKDC P78527 4/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
ACE P12821 1/20 0.49
ECE1 P42892 1/20 0.49
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
MAPT P10636 4/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 2/20 0.45
TSHR P16473 2/20 0.45
HCRTR1 O43613 1/20 0.45
TP53 P04637 1/20 0.45
LMNA P02545 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSD17B10 Q99714 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8752326 0.88 MAPT (0.50) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7326699 0.81 MAPT (0.55) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7320806 0.81 PRKDC (0.54) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7319096 0.78 PRKDC (0.54) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7314957 0.78 PRKDC (0.54) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7328899 0.78 PRKDC (0.54) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL7327192 0.77 ABCG2 (0.52) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL29160432 0.77 KMT2A (0.42) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL29160433 0.77 KMT2A (0.42) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1
SCHEMBL29160440 0.77 KMT2A (0.42) KMT2ASMN1; SMN2PRKDCKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5703075-A Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones PHARMACIA & UPJOHN COMPANY (US) 1997-12-30 US disclosed
EP-0525123-B1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES UPJOHN CO (US) 1997-09-17 EP disclosed
EP-0525123-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES. UPJOHN CO (US) 1993-02-03 EP disclosed
WO-1991019707-A2 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES THE UPJOHN COMPANY (US) 1991-12-26 WO disclosed
EP-0459983-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES PHARMACIA & UPJOHN COMPANY (US) 1991-12-11 EP disclosed
WO-1990006921-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES THE UPJOHN COMPANY (US) 1990-06-28 WO disclosed